ABL2
Top View
- Tyrosine Kinase Panel
- Paralog-Specific Patterns of Structural Disorder and Phosphorylation in the Vertebrate SH3–SH2–Tyrosine Kinase Protein Family
- Role of Non Receptor Tyrosine Kinases in Hematological Malignances and Its Targeting by Natural Products Kodappully S
- Chemical Proteomics Reveals Target Selectivity of Clinical Jak Inhibitors in Human Primary Cells Received: 18 April 2019 H
- Kinases That Are Currently Stored in the Phospho.ELM Database
- Deciphering Human Cytoplasmic Protein Tyrosine Kinase Phosphorylation Specificity in Yeast
- Global Target Profile of the Kinase Inhibitor Bosutinib in Primary
- Genetic Alterations in B-Acute Lymphoblastic Leukemia
- Evidence for Activated Lck Protein Tyrosine Kinase As the Driver Of
- ABL2 Polyclonal Antibody Catalog Number:17693-1-AP Featured Product 5 Publications
- Identification of FDA-Approved Oncology Drugs with Selective Potency in High-Risk
- Sequence Specificity of Src Homology 2 Domains
- Digitalcommons@TMC
- The Btk Tyrosine Kinase Is a Major Target of the Bcr-Abl Inhibitor Dasatinib
- Inkascore.Org Phosphoproteomics Data Analysis Version 0.2.1 Running
- Technical Specifications Comprehensive Tumor Profiling For
- Evidence for Activated Lck Protein Tyrosine Kinase As the Driver of Proliferation in Acute Myeloid Leukemia Cell, CTV-1 Li Li University of Rhode Island
- ABL2, Active Recombinant Protein Expressed in Sf9 Cells